Method that rapidly predicts breast cancer survival rates clinically validated
Digistain, a company with its roots at Imperial, has proven the worth of its breast cancer assessment method in a significant clinical trial.
Jan 29, 2024
0
0
Digistain, a company with its roots at Imperial, has proven the worth of its breast cancer assessment method in a significant clinical trial.
Jan 29, 2024
0
0
A simple blood test could help diagnose patients with the deadliest form of brain cancer, sparing them from undergoing invasive, highly-risky surgery.
Jan 26, 2024
0
3
A driving simulation study has shown we are one step closer to monitoring our heart health in real time via a tiny device worn in the ear.
Jan 16, 2024
0
75
Studying strange forms of RNA associated with the formation of aggregates in the brains of ALS patients could lead to new avenues for treatments.
Dec 18, 2023
0
40
A study looking at 15 years of HIV transmission and suppression in Uganda reveals how closing gender gaps in treatment could slash infection rates.
Dec 8, 2023
1
30
Increasing the amount of folate through our diet or taking supplements could help to reduce bowel cancer risk.
Nov 30, 2023
0
174
Minimally invasive focal therapies for prostate cancer are associated with a lower overall cost and improved quality of life for patients.
Nov 24, 2023
0
2
Scientists from the Department of Brain Sciences have discovered that the circadian clock regulates axonal regeneration and repair.
Nov 24, 2023
0
28
A new AI tool from Kheiron Medical Technologies and Imperial College London can detect up to 13% more breast cancers than humans in breast screenings.
Nov 20, 2023
0
47
Some patients with chest pain from reduced blood flow to the heart may benefit from having a stent implanted, instead of chest pain medications.
Nov 13, 2023
0
11